GoHealth, Inc.
GOCO
$0.87
$0.000.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -96.75% | -71.10% | -11.17% | 19.06% | 40.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -96.75% | -71.10% | -11.17% | 19.06% | 40.63% |
| Cost of Revenue | -91.67% | 2.09% | 56.72% | 3.31% | 27.14% |
| Gross Profit | -97.54% | -85.71% | -27.65% | 23.11% | 42.99% |
| SG&A Expenses | -85.20% | -42.24% | -18.57% | 19.38% | 25.45% |
| Depreciation & Amortization | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -85.52% | -27.97% | -4.12% | 11.81% | 22.38% |
| Operating Income | -139.38% | -91.59% | -14.25% | 598.82% | 223.89% |
| Income Before Tax | -202.15% | -2,147.57% | -96.01% | 59.45% | 3,252.17% |
| Income Tax Expenses | -250.61% | -4,318.18% | -782.50% | 1,652.11% | 530.34% |
| Earnings from Continuing Operations | -200.15% | -2,142.94% | -95.55% | 54.16% | 2,627.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 178.44% | 1,823.57% | 85.22% | -55.66% | -3,139.89% |
| Net Income | -227.78% | -2,547.91% | -108.79% | 52.17% | 2,180.67% |
| EBIT | -139.38% | -91.59% | -14.25% | 598.82% | 223.89% |
| EBITDA | -113.69% | -236.75% | -41.14% | 55.86% | 126.70% |
| EPS Basic | -186.19% | -2,132.39% | -89.11% | 50.30% | 1,195.61% |
| Normalized Basic EPS | -202.68% | 222.64% | 639.10% | 2,305.17% | 21.93% |
| EPS Diluted | -239.00% | -2,639.72% | -89.11% | 50.30% | 779.36% |
| Normalized Diluted EPS | -265.56% | 277.45% | 639.10% | 2,305.17% | -24.37% |
| Average Basic Shares Outstanding | 58.67% | 40.28% | 8.59% | 6.77% | 5.95% |
| Average Diluted Shares Outstanding | -1.60% | -3.05% | 8.59% | 6.77% | 70.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |